Rheumatic Disease & COVID-19 - The Rheumatologist

This question is drawn from "COVID-19: Most Individuals with Rheumatic Disease Recover," The Rheumatologist, August 2020.

Using data in the COVID-19 Global Rheumatology Alliance registry, researchers reviewed data for 600 patients from 40 countries with rheumatologic disease who developed COVID-19. Which of the following is true of the findings from this cohort?

A. Hydroxychloroquine use was associated with a lower risk of hospitalization.

B. Use of prednisone ≥10 mg daily was associated with an increase in the risk of hospitalization.

C. TNF inhibitor use was associated with a significantly higher risk of hospitalization.

D. NSAIDs were associated with a higher risk of hospitalization.